Influenza B
24
2
2
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
1 terminated out of 24 trials
93.8%
+7.2% vs benchmark
13%
3 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (24)
Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test
Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test
Covid Flu A/B and RSV 4 in 1 Diagnostic Test
Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)
Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings
Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use
SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites
Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI
Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections
MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study
Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel
Dose, Safety, and Pathogenicity of a New Influenza B Strain
Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza